Pillar Clinical Research

Richardson, Texas 75080

3 studies enrolling now · 14 studies all time

What they study most

Adjunctive Treatment of Major Depressive Disorder, Binge Eating Disorder, Bipolar Disorder Type I With Mania or Mania With Mixed Features, Bipolar I Disorder, Borderline Personality Disorder, Major Depressive Disorder, Methamphetamine Abuse, Methamphetamine-dependence, Moderate to Severe Opioid Use Disorder, Schizophrenia, Schizophrenia; Psychosis, Smoking

Studies at this site

• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. — Recruiting now
• 52-week Open Label Safety-Tolerability Study — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) — Recruiting now
• A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
• INDV-6001 Multiple-Dose Pharmacokinetic Study — Completed
• Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia — Completed
• Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 — Stopped early
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) — Completed
• BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects — Completed
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia — Stopped early
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® — Stopped early
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder — Completed
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) — Completed